Opioid reduction in ambulatory thyroid and parathyroid surgery after implementing enhanced recovery after surgery protocol

Background Opioid abuse is widespread in the United States and the risk for chronic use is increased in surgical patients, including patients with thyroid and parathyroid. Methods Records for 171 patients prior to and 67 patients following implementation of an enhanced recovery after surgery (ERAS)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Head & neck 2021-05, Vol.43 (5), p.1545-1552
Hauptverfasser: Lide, Riley C., Creighton, Erin Weatherford, Yeh, Jessica, Troughton, Mikayla, Hollowoa, Blake, Merrill, Tyler, Robbins, Alexa, Orman, Gray, Breckling, Meghan, Vural, Emre, Moreno, Mauricio, Stack, Brendan C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Opioid abuse is widespread in the United States and the risk for chronic use is increased in surgical patients, including patients with thyroid and parathyroid. Methods Records for 171 patients prior to and 67 patients following implementation of an enhanced recovery after surgery (ERAS) protocol for ambulatory thyroid/parathyroid surgeries were reviewed. The ERAS included superficial cervical plexus block, multimodal premedication, and postoperative reliance on acetaminophen and ibuprofen with judicious prescribing of opioids. Results Post‐ERAS patients were prescribed a mean 72 morphine milligram equivalents (MME); pre‐ERAS patients were prescribed a mean 163 MME (p 
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.26617